UNICREDIT BANK GMBH | Real-time Borsa Italiana 12:33:39 31/05/2024 BST | ||
| 92.95 EUR | +0.01% |
|
| Current month | +0.97% | ||
| 1 month | +0.97% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
CUREVAC N.V.
Latest news about CUREVAC N.V.
More news
| Date | Price | Change |
|---|---|---|
| 31/05/24 | 92.95 | +0.01% |
| 30/05/24 | 92.94 | -0.23% |
| 29/05/24 | 93.15 | +0.12% |
| 28/05/24 | 93.04 | -0.56% |
| 27/05/24 | 93.56 | +0.25% |
Real-time Borsa Italiana
Last update May 31, 2024 at 12:33 pm
More quotesStatic data
| Product type | 100% Guarantee Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | CUREVAC N.V. |
| Issuer | 
UniCredit
|
| UC3UPY | |
| ISIN | DE000HC3UPY8 |
| Date issued | 03/02/2023 |
| Strike | 9.401 $ |
| Maturity | 21/12/2028 (1666 Days) |
| Parity | 0.09 : 1 |
| Emission price | 100 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 101.2 € |
|---|---|
| Lowest since issue | 91.65 € |
| Spread | 1.86 € |
| Spread % | 1.98% |
Company Profile
CureVac AG is a clinical-stage biopharmaceutical company, The Company strives to create transformative medicines to protect and improve peopleâs lives. Fueled by proprietary RNA technology platform combined with two decades of science and manufacturing, The Company is dedicated to creating novel treatments that enable the body to make its own prophylactic and therapeutic drugs.
Sector
-
Consensus: CureVac N.V.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
3.477
EUR
Average target price
8.728
EUR
Spread / Average Target
+151.04%
- Stock Market
- Certificates
- UC3UPY Certificat
